KRISTINA MARKONIOS: Open Payments
NPI 1184063158 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 70 payments from 19 companies in 2025. Trend: 2023 $1,770 · 2024 $1,209 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $208 |
| Axsome Therapeutics, Inc. | 8 | $188 |
| Alkermes, Inc. | 9 | $176 |
| ABBVIE INC. | 10 | $145 |
| Otsuka America Pharmaceutical, Inc. | 7 | $142 |
| Vanda Pharmaceuticals Inc. | 3 | $95 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
Products named: CAPLYTA, REXULTI, ARISTADA, VRAYLAR, Auvelity, COBENFY, TRINTELLIX, HETLIOZ.
Industry payments across FL — which companies pay providers there.
